Stock Research for AMRN

AMRN
Current Price

$3.6950


Latest Update: 2018-02-23 16:00:00

High
$ 3.7000
Low
$ 3.6900
Close
$ 3.7000
Volume
27753
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

AMRN Stock Chart & Research Data

The AMRN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AMRN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AMRN Due diligence Resources & Stock Charts

The AMRN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AMRN Detailed Price Forecast - CNN Money CNN View AMRN Detailed Summary - Google Finance
Yahoo View AMRN Detailed Summary - Yahoo! Finance Zacks View AMRN Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AMRN Trends & Analysis - Trade-Ideas Barrons View AMRN Major Holders - Barrons
NASDAQ View AMRN Call Transcripts - NASDAQ Seeking View AMRN Breaking News & Analysis - Seeking Alpha
Spotlight View AMRN Annual Report - CompanySpotlight.com OTC Report View AMRN OTC Short Report - OTCShortReport.com
TradeKing View AMRN Fundamentals - TradeKing Charts View AMRN SEC Filings - Bar Chart
WSJ View Historical Prices for AMRN - The WSJ Morningstar View Performance/Total Return for AMRN - Morningstar
MarketWatch View the Analyst Estimates for AMRN - MarketWatch CNBC View the Earnings History for AMRN - CNBC
StockMarketWatch View the AMRN Earnings - StockMarketWatch MacroAxis View AMRN Buy or Sell Recommendations - MacroAxis
Bullish View the AMRN Bullish Patterns - American Bulls Short Pains View AMRN Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AMRN Stock Mentions - StockTwits PennyStocks View AMRN Stock Mentions - PennyStockTweets
Twitter View AMRN Stock Mentions - Twitter Invest Hub View AMRN Investment Forum News - Investor Hub
Yahoo View AMRN Stock Mentions - Yahoo! Message Board Seeking Alpha View AMRN Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for AMRN - SECform4.com Insider Cow View Insider Transactions for AMRN - Insider Cow
CNBC View AMRN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AMRN - OTC Markets
Yahoo View Insider Transactions for AMRN - Yahoo! Finance NASDAQ View Institutional Holdings for AMRN - NASDAQ


Stock Charts

FinViz View AMRN Stock Insight & Charts - FinViz.com StockCharts View AMRN Investment Charts - StockCharts.com
BarChart View AMRN Stock Overview & Charts - BarChart Trading View View AMRN User Generated Charts - Trading View


Latest Financial News for AMRN

Amarin to Report Fourth Quarter and Full Year 2017 Results and Host Conference Call on February 27th, 2018
Posted on Tuesday February 20, 2018

BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 20, 2018-- Amarin Corporation plc, a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, ...


Amarin Prices Public Offering of American Depositary Shares
Posted on Tuesday January 30, 2018

BEDMINSTER, N.J. and DUBLIN, Ireland, Jan. 30, 2018-- Amarin Corporation plc today announced the pricing of the underwritten public offering of its American Depositary Shares for gross proceeds of approximately ...


Amarin Corporation plc (ADR) (AMRN) Cashes Out; Shares Tumble
Posted on Monday January 29, 2018

With its stock trading near a 52-week high, Amarin Corporation plc (ADR) (NASDAQ:AMRN) is cashing out at the top. On Monday, Amarin announced a registered underwritten public offering of its American Depositary Shares. Amarin intends to use the net proceeds from the offering to expand medical education and market awareness initiatives, including, in advance of REDUCE-IT results being known, pilot testing of new promotional initiatives for potential broader application following REDUCE-IT results, to increase its inventory balances for incremental inventory build prior to REDUCE-IT results and for general corporate and working capital purposes.


Amarin Announces Proposed Public Offering of American Depositary Shares
Posted on Monday January 29, 2018

BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 29, 2018-- Amarin Corporation plc today announced a registered underwritten public offering of its American Depositary Shares. All of the shares in the proposed ...


Amarin Corporation plc (ADR) (AMRN) Cashes Out; Shares Tumble
Smarter Analyst - Jan 29, 2018
With its stock trading near a 52-week high, Amarin Corporation plc (ADR) (NASDAQ:AMRN) is cashing out at the top. On Monday, Amarin announced a registered underwritten public offering of its American Depositary Shares.

Amarin Corporation plc (ADR) (NASDAQ:AMRN) Is A Big Winner For Us; Here's What ...
Insider Financial - Jul 5, 2017
Amarin is trying to bring a drug to market, Vascepa, in a target indication of MACE risk patients, with the goal being to have the drug serve as an adjuvant to the current standard of care treatment, statins.

Cantor Pounds The Table On Amarin Corporation plc (ADR) (AMRN)
Smarter Analyst - Jun 26, 2017
Cantor analyst Louise Chen was out pounding the table on shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN), assuming an Overweight rating and price target of $10.00, which represents a potential upside of 190% from where the stock is currently ...

Amarin Corporation plc (ADR) (AMRN) Announces Two EPA-Related Data Presentations
Smarter Analyst - Jun 12, 2017
Amarin expects that the trial will run to completion and that the onset of the target final primary cardiovascular event will likely be reached near the end of 2017.

Enter a stock symbol to view the stock details.